On February 2, 2018, the Judicial Panel on Multidistrict Litigation (JPML) centralized federal lawsuits filed by individuals who have suffered heart failure after taking the diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR) in multidistrict litigation (“MDL”) in the U.S. District Court, Eastern District of Kentucky before the Honorable Karen K. Caldwell. Saxagliptin is...
HEART FAILURE FROM DIABETES DRUGS, ONGLYZA & KOMBIGLYZE XR- Federal Cases Centralized in the Eastern District of Kentucky
